Improving Access to Care for Veterans With Memory Loss

Part of paid clinical trials in Pittsburgh, Pennsylvania.

Sponsor
VA Pittsburgh Healthcare System
Study ID
NCT07117162
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • ADRD Care Delivery Protocol — OTHER
    1\. Included in arm/group descriptions

Study Details

This study evaluates a care delivery protocol to improve access to care for Veterans with Alzheimer's Disease and Related Disorders (ADRD). A randomized controlled trial will enroll Veterans with mild cognitive impairment or early dementia at VA Pittsburgh. The ADRD care delivery protocol integrates telehealth, advanced diagnostics, and streamlined workflows to expedite screening for eligibility for amyloid targeting therapies.

Key Dates

Start date
Oct 29, 2025
Status verified
Oct 2025
Primary completion
Jun 30, 2027
Completion
Jun 30, 2027

Study Design

Enrollment
30 participants (estimated)
Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: ADRD Care Delivery Protocol
    Patients will undergo telehealth preparedness assessment, cognitive screening, and blood biomarker testing prior to the initial consultation with the specialist.
  • No Intervention: Usual Care
    Patients will undergo usual care with all evaluation and testing at the discretion of the specialist.

Primary Outcome Measure

Time to Eligibility Determination [ Time Frame: From date of randomization until the date of determination of eligibility for monoclonal antibody therapy, assessed up to 12 months. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
VA Pittsburgh Healthcare SystemPittsburghPennsylvania15240
Alison O'Donnell, DO, MPH
412-522-3123
Julie Faieta, PhD
Alison O'Donnell, DO, MPH (PRINCIPAL_INVESTIGATOR)
Julie Faieta, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Pittsburgh, PA

Related Studies